Sagimet Biosciences Inc. (SGMT) Misses Q2 EPS by 3529c
Tweet
Share
E-mailGet Alerts SGMT Hot Sheet
Join SI Premium – FREE
Sagimet Biosciences Inc. (NASDAQ: SGMT) reported Q2 EPS of ($35.80), $35.29 worse than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Sagimet Biosciences Inc. (SGMT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Nike names former Pfizer CFO David Denton as new finance chief
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
